During the past decade, Catalina Research Institute, LLC conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 49 clinical trials were completed, i.e. on average, 75.4% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 31 clinical trials were completed. i.e. 88.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Catalina Research Institute, LLC" #1 sponsor was "Eli Lilly and Company" with 19 trials, followed by "Pfizer" with 7 trials sponsored, "Sunovion" with 5 trials sponsored, "Bristol-Myers Squibb" with 4 trials sponsored and "NuSirt Biopharma" with 4 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Catalina Research Institute, LLC" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Camurus AB" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Google LLC." with 1 trials as a collaborator and "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Catalina Research Institute, LLC" are "Type 2 Diabetes" (9 trials), "Type 2 Diabetes Mellitus" (9 trials), "Non-Alcoholic Fatty Liver Disease" (6 trials), "Schizophrenia" (6 trials) and "Low Back Pain" (5 trials). Many other conditions were trialed in "Catalina Research Institute, LLC" in a lesser frequency.

Most popular intervention types in "Catalina Research Institute, LLC" are "Drug" (81 trials), "Other" (13 trials), "Biological" (2 trials), "Dietary Supplement" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "Tirzepatide" (10 trials), "Dulaglutide" (4 trials), "Insulin Degludec" (4 trials) and "Buprenorphine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Catalina Research Institute, LLC" are 85 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Catalina Research Institute, LLC". undefined are not yet recruiting, 7 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Catalina Research Institute, LLC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Catalina Research Institute, LLC, 4 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".